Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy
- PMID: 33524477
- PMCID: PMC7845554
- DOI: 10.1016/j.annonc.2021.01.069
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment in
-
Estrogen and COVID-19: friend or foe?Ann Oncol. 2021 Jul;32(7):933-934. doi: 10.1016/j.annonc.2021.03.201. Epub 2021 Mar 29. Ann Oncol. 2021. PMID: 33794291 Free PMC article. No abstract available.
References
-
- Rugge M., Zorzi M., Guzzinati S. SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer. Nat Cancer. 2020;1(8):784–788. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
